
Pete Jackson, PhD

FasterCures Quarterly Update: July 2023

Exploring the Impact of the 21st Century Cures Act

Patient-Reported Outcomes: Design with the End in Mind

Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders

Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Tackling COVID-19 in Nigeria: Health Tech Rising to the Challenge

Los Angeles Business Journal Names Milken Institute Research Organization of the Year

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870

Mobilizing Stalled Assets from Big Pharma for Neglected Patient Groups
